Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ClearPoint Neuro Q4 2023 GAAP EPS $(0.19) Beats $(0.20) Estimate, Sales $6.810M Beat $6.533M Estimate

Author: Benzinga Newsdesk | March 12, 2024 04:27pm
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. The company reported quarterly sales of $6.810 million which beat the analyst consensus estimate of $6.533 million by 4.23 percent. This is a 31.62 percent increase over sales of $5.174 million the same period last year.

Posted In: CLPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist